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Mandibuloacral dysplasia (MAD) is a rare autosomal recessive disorder, characterized by postnatal growth retar-
dation, craniofacial anomalies, skeletal malformations, and mottled cutaneous pigmentation. The LMNA gene
encoding two nuclear envelope proteins (lamins A and C [lamin A/C]) maps to chromosome 1q21 and has been
associated with five distinct pathologies, including Dunnigan-type familial partial lipodystrophy, a condition that
is characterized by subcutaneous fat loss and is invariably associated with insulin resistance and diabetes. Since
patients with MAD frequently have partial lipodystrophy and insulin resistance, we hypothesized that the disease
may be caused by mutations in the LMNA gene. We analyzed five consanguineous Italian families and demonstrated
linkage of MAD to chromosome 1q21, by use of homozygosity mapping. We then sequenced the LMNA gene and
identified a homozygous missense mutation (R527H) that was shared by all affected patients. Patient skin fibroblasts
showed nuclei that presented abnormal lamin A/C distribution and a dysmorphic envelope, thus demonstrating
the pathogenic effect of the R527H LMNA mutation.
Mandibuloacral dysplasia (MAD [MIM 248370]) is a
rare autosomal recessive disorder characterized by man-
dibular and clavicular hypoplasia, acroosteolysis, delayed
closure of the cranial suture, joint contractures, and types
A and B patterns of lipodystrophy (Cavallazzi et al. 1960;
Young et al. 1971; Freidenberg et al. 1992; Simha and
Garg 2002). We identified five consanguineous pedigrees
that included nine individuals affected by MAD. All fam-
ilies originated from a sparsely populated area in central
Italy, suggesting the existence of a founder effect (Tenconi
et al. 1986; Tudisco et al. 2000). Patients were born at
full term after an uneventful pregnancy. Developmentwas
considered unremarkable during the first 4–5 years of life.
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At this time, growth retardation, clavicular dysplasia, de-
layed closure of the cranial suture, and fingertip rounding
were noted. Reexamination of patients revealed subtotal
alopecia (only in male patients), micrognathia, premature
loss of teeth, and dental overcrowding. Hepatomegaly,
acanthosis nigricans in the axillae and groin, togetherwith
mottled areas of hyperpigmentation over the lower trunk,
upper thighs, and distal lower limbs were found. Patients
also presented acro-osteolysis, stiff joints, and hypoplastic
clavicles (fig. 1). In all patients, dual-energy x-ray ab-
sorbtiometry (DEXA) revealed loss of subcutaneous fat
in the extremities and identified fat accumulation in
the trunk, face, submental region, and occiput (buffalo
hump). All patients displayed normal fasting plasma-
glucose concentrations; however, oral glucose-tolerance
tests revealed marked basal and post-load hyperinsuli-
nemia, indicating insulin resistance. Thesemetabolic char-
acteristics and similar partial lipodystrophy, are the main
features of the Dunnigan-type familial partial lipodystro-
phy (FPLD), which has been shown to be caused by mu-
tations in the lamin A/C gene (LMNA [MIM 150330])
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Figure 1 Clinical spectrum of MAD. A, Alopecia, micrognathia, and hanging shoulders (patient VII1, family 1). B, X-ray films showing
hypoplastic clavicles (patient 4). C, Lipodystrophy, hyperpigmentation, and acroosteolysis in lower limbs (patient VII-1).D, X-ray films showing
marked osteolysis of the distal phalanges (patient VII1). E, short distal phalanges, “joint stick deformities” of the fingers with areas of skin
atrophy over the hand (patient VII1).
(Shackleton et al. 2000). In addition, recessive mutations
of this gene cause more-severe phenotypes (Raffaele di
Barletta et al. 2000; De Sandre-Giovannoli et al. 2002).
For these reasons, we thought it worthwhile to screen for
the LMNA gene in our patients with MAD. We therefore
focused our attention on 1q21 chromosome region where
LMNA gene is located. This gene encodes lamins A and
C (lamin A/C) by alternative splicing. These proteins are
major components of the nuclear lamina, a fibrous net-
work underlying the inner surface of the nuclear envelope
(Lin and Worman 1993). LMNA mutations cause five
distinct diseases: autosomal dominant and recessive Em-
ery-Dreifuss muscular dystrophy (EDMD) (Bonne et al.
1999; Raffaele di Barletta et al. 2000), limb-girdle mus-
cular dystrophy type 1B (Muchir et al. 2000), dilated
cardiomyopathy type 1A (Fatkin et al. 1999; Be´cane et
al. 2000), autosomal recessive Charcot-Marie-Tooth dis-
ease type 2 (De Sandre-Giovannoli et al. 2002) and Dun-
nigan-type FPLD (Cao and Hegele 2000; Shackleton et
al. 2000; Speckman et al. 2000). The last condition is
characterized by loss of subcutaneous fat from the ex-
tremities and excess fat in the face, neck, and trunk (Dun-
nigan et al. 1974). This pattern of lipodystrophy is very
similar to the one observed in the patients we examined
and in affected individuals reported elsewhere (Simha and
Garg 2002). Moreover, patients with MAD, as well as
those with FPLD, display insulin resistance and associated
metabolic derangements, including diabetes and dyslipi-
demia (Simha and Garg 2002).
To test linkage of MAD to the LMNA locus, we an-
alyzed D1S1664, D1S305, D1S2715, D1S303, D1S2721,
and D1S2624 microsatellite markers. Alleles were am-
plified using fluorescently labeled primers and were
separated on an ABI 310 genetic analyzer (Applied Bio-
systems). Genotypes were determined using the GENO-
TYPER 2.0 software (Applied Biosystems), and haplo-
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Figure 2 A mutation in LMNA that underlies MAD. A, Haplotype analysis in four families with MAD, using nine polymorphic markers
on 1q21.2-q21.3. The shared disease-associated haplotype is boxed. B, Sequence analysis showing a homozygous GrA substitution at cDNA
position 1580. Upon digestion with RsaI, amplicons of exon 9, which normally produce two fragments (130 bp and 62 bp) (lanes 7, 8, and
9, control subjects), yield only one in affected individuals (lanes 1, 2, 3, and 4, F1-VII-1, F2-II-2, F3-II-2, and F4-II-1, respectively) and three
in heterozygous carriers (lanes 5 and 6, F2-I-1 and F2-I-2, respectively). C, Schematic representation of mutations located within lamin A/C
proteins and their phenotypic effects. AD p autosomal dominant; AR p autosomal recessive; CD p conduction disease; DCM p dilated
cardiomyopathy.
types were derived by minimizing recombination events.
Multipoint analysis was implemented using the MAP-
MAKER/HOMOZ software (Kruglyak et al. 1995).
Genotyping results are reported in figure 2A, which
shows that markers D1S2715 and D1S2721 are homo-
zygous and identical by descent in all affected individuals.
Accordingly, multipoint analysis identified a maximum
LOD score of 9.05 in the interval defined by D1S2715
and D1S2721. Control DNA from healthy unrelated in-
dividuals of Italian origin was used to determine allele
frequencies of six markers: two microsatellite markers
(D1S2715 and D1S2721) and four SNPs localized in
LMNA (three silent exonic SNPs: A287 [861T/C], D446
[1338T/C], andH566 [1698C/T] [Vigouroux et al. 2000];
and one intronic SNP [IVS616G/A]) [unpublished data,
P. Richard and G.B.]) for which families with MAD
shared a common haplotype (fig. 2A). This disease-bear-
ing haplotype was not detected in healthy control indi-
viduals ( ). Taken together, these results stronglynp 96
suggest that all Italian families with MAD originate from
a common founder.
We subsequently sequenced LMNA exons in patients
with MAD and in their consanguineous relatives. In all
nine patients, we identified the same homozygous tran-
sition, 1580GrA, which changes arginine 527 to his-
tidine (R527H) (fig. 2B). Because the mutation removes
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Figure 3 Immunofluorescence analysis of wild-type, heterozy-
gous and homozygous R527H cultured skin fibroblasts.A and B,Con-
trol fibroblasts, with most nuclei having a normal ovoid shape. C and
D,Heterozygous R527H fibroblasts, with most nuclei having a normal
ovoid shape. Lamin A/C labeling shows a honeycomb pattern of dis-
tribution. E and F, Homozygous R527H fibroblasts, showing abnor-
mal nucleus morphology, with some lobules of the nuclear envelope
(arrows). Lamin A/C was located all around the nuclear envelope, in
which lamin A/C labeling shows a honeycomb pattern of distribution.
Immunofluorescence microscopy was performed by use of anAxiophot
microscope (Carl Zeiss). The pictures were processed with Adobe Pho-
toshop, version 5.5. Bar p 5 mm. Labeling procedures are described
in the text.
an RsaI site, we were able to screen for the presence of
mutation in all family members (fig. 2B) and all samples
from unrelated control individuals from the same ethnic
background, for confirmation. The mutation was pre-
sent in a heterozygous state in healthy parents and was
absent in 300 unaffected individuals.
To confirm the pathogenic effect of R527H mutation
involved in MAD, we analyzed cultured skin fibroblasts
from patient VII-1 of family 1 and his unaffectedmother
(VI-2), who were found to carry the R527H lamin A/C
mutation in homozygous and heterozygous states, re-
spectively. Cells were fixed and permeabilized (Yang et
al. 1997), DNA was stained with 4′, 6-diamino-2-phen-
ylindole, and lamin A/C was labeled using a lamin A/C–
specific antibody (mAb 4A7 [kindly provided by G. Mor-
ris]). In control fibroblasts, nuclei are round or ovoid, and
lamin A/C is localized at the nuclear envelope (fig. 3A
and 3B). In heterozygous R527H fibroblasts of the
mother, most nuclei have normal morphology, but
∼10% of the nuclei show a honeycomb immunoflu-
orescence pattern for lamin A/C distribution (fig. 3C and
3D). It is noteworthy that parents do not display any
of the bone, cutaneous, or fat abnormalities of the af-
fected son, and their appearance is completely normal;
furthermore, although metabolic investigations were not
performed, results of a thorough physical examination
were unremarkable. In homozygous R527H fibroblasts
of the patient, 10% of the nuclei show lobulation of
their nuclear envelope (fig. 3E and 3F), with a honey-
comb labeling of lamin A/C. Elsewhere, similar abnor-
malities of skin-fibroblast nuclei have been reported in
patients with FPLD who harbor R482Q or R482W mu-
tations (Vigouroux et al. 2001) and in other patients
with autosomal dominant EDMD (authors’ unpublished
data). Earlier observations (unpublished data, A.M. and
G.B.) demonstrated that the R527H LMNA mutation
identified in patients with MAD perturbs the correct as-
sembly of nuclear lamina, but this mechanical instability
is not specific to this disease. These results expand our
knowledge of laminopathies and provide evidence of a
wide range of effects of this protein on human devel-
opment and differentiation. The R527 amino acid is lo-
cated in the C-terminal domain common to lamin A and
lamin C, which has an immunoglobulin-like three-di-
mensional structure (Dhe-Paganon et al. 2002; Krimm
et al. 2002). R527 is localized at the external surface of
the domain, and thus R527H substitution would disrupt
the surface structure of the protein, altering binding fun-
damental sites. Interestingly, Lloyd et al. (2002) have
identified a binding site of lamin A for the adipocyte-
differentiation factor sterol-response element–binding
protein 1 (SREBP1) between residues 227 and 487. This
argues for the possibility that fat loss observed in FPLD
and MAD may be caused by reduced binding of the
adipocyte-differentiation factor SREBP1 to lamin A. In
addition, it is interesting to note that we described het-
erozygous R527P mutation in patients with autosomal
dominant EDMD, a condition that specifically affects
striated muscle tissue (Bonne et al. 1999), and that, in
some of these patients, partial lipodystrophy was ob-
served (van der Kooi et al., in press). In contrast, patients
with MAD who bear the R527H mutation displayed
neither symptoms nor signs of muscle involvement: pa-
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tients showed no detectable muscle wasting or weakness,
and their creatine kinase levels were in the normal range.
In addition, patients did not report any cardiac symp-
toms, and results of electrocardiograms were normal.
The molecular structures of both arginine and histidine
are basic, and therefore such change could explain the
absence of phenotypic effects in individuals carrying het-
erozygous R527H. Conversely, proline is hydrophobic
and is known to introduce structural change, and thus
a R527P mutation is expected to produce an abnormal
phenotype. Such phenotypic variability was previously
reported for H222P and H222Y mutations, which were
associated with autosomal dominant and autosomal re-
cessive EDMD, respectively (Bonne et al. 2000; Raffaele
di Barletta et al. 2000). Similar instances of allele spec-
ificity that produce different developmental syndromes
have been reported for disorders related to fibroblast
growth receptor factor and in the p53 homologue p63
(van Bokhoven and McKeon 2002). In the case of lamin
A/C, allelic disorders may be caused by the differential
disruption of domains involved in tissue-specific inter-
actions. Indeed, several transcription factors involved in
tissue differentiation are associated with the nuclear ma-
trix, and it has been demonstrated that mutations that
interfere with this process can severely affect transcrip-
tion-factor function (Stenoien et al. 2000). On this ba-
sis, we speculate that the primary defect that charac-
terizes lamina disruption may have downstream effects
on chromatin structure or gene expression. The effects
of the latter may be responsible for the tissue-specific
pathology in human laminopathies.
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